Prodrug is a useful approach for improving the bioavailability of therapeutic agents through increased passive transport. Carboxylesterases (CESs, EC.3.1.1.1.) that show ubiquitous expression proˆles play an important role in the biotransformation of ester-containing prodrugs into their therapeutically active forms in the body. High levels of CESs are found in the liver, small intestine and lungs where prodrugs areˆrstly hydrolyzed before entering the systemic circulation. Rat intestine single-pass perfusion experiments have shown that CES is involved in the intestinalˆrst-pass hydrolysis. Extensive pulmonaryˆrst-pass hydrolysis has been observed in accordance to the substrate speciˆcity of CES1 isozyme. Hydrolysis in the human liver and lungs is mainly catalyzed by hCE1 (a human CES1 family isozyme), whereas that in the small intestine is predominantly mediated by hCE2 (a human CES2 family isozyme). hCE2 preferentially hydrolyzes substrates with a small acyl moiety such as CPT-11, due to conformational steric hindrance in its active site. In contrast, hCE1 is able to hydrolyze a variety of substrates due to spacious and ‰exible substrate binding region in its active site. In addition, hCE1 has been found to catalyze transesteriˆcation. Caco-2 cells mainly expresses CES1 isozyme but not CES2 isozyme. Because of the diŠerences in substrate speciˆcity between CES1 and CES2 enzymes, Caco-2 cell monolayer is not suitable for predicting intestinal absorption of prodrugs. Theseˆndings indicate that identiˆcation of substrate speciˆcity of CES isozymes and development of an in vitro experimental method are essential to support rational design of prodrug.
Prodrug is a useful approach for improving the bioavailability of therapeutic agents through increased passive transport. Carboxylesterases (CESs, EC.3.1.1.1.) that show ubiquitous expression proˆles play an important role in the biotransformation of ester-containing prodrugs into their therapeutically active forms in the body. High levels of CESs are found in the liver, small intestine and lungs where prodrugs areˆrstly hydrolyzed before entering the systemic circulation. Rat intestine single-pass perfusion experiments have shown that CES is involved in the intestinalˆrst-pass hydrolysis. Extensive pulmonaryˆrst-pass hydrolysis has been observed in accordance to the substrate speciˆcity of CES1 isozyme. Hydrolysis in the human liver and lungs is mainly catalyzed by hCE1 (a human CES1 family isozyme), whereas that in the small intestine is predominantly mediated by hCE2 (a human CES2 family isozyme). hCE2 preferentially hydrolyzes substrates with a small acyl moiety such as CPT-11, due to conformational steric hindrance in its active site. In contrast, hCE1 is able to hydrolyze a variety of substrates due to spacious and ‰exible substrate binding region in its active site. In addition, hCE1 has been found to catalyze transesteriˆcation. Caco-2 cells mainly expresses CES1 isozyme but not CES2 isozyme. Because of the diŠerences in substrate speciˆcity between CES1 and CES2 enzymes, Caco-2 cell monolayer is not suitable for predicting intestinal absorption of prodrugs. Theseˆndings indicate that identiˆcation of substrate speciˆcity of CES isozymes and development of an in vitro experimental method are essential to support rational design of prodrug. Protein content of rat liver microsomes is 1280 mg/kg. Protein content of S9 fraction of dog liver, lung, and kidney is 3220 mg/kg, 425 mg/kg, and 423 mg/kg, respectively. Unbound fraction of butyryl-PL in blood (f b ) was 0.09. CLint was calculated by Vmax/Km×(protein content). CLorg for liver and kidney was calculated by Q×f b ×CL int /(Q ＋f b ×CL int ), and that for lung was calculated by f b ×CL int . The organ microsomes were obtained from Gentenst (1) and Tissue Transformation Technologies (2), respectively. Polyacrylamide gel electrophoresis of liver and small intestine microsomes (5 mg), Caco-2 cell S9 (15 mg) was followed by staining for esterase activity using a-naphthylbutyrate.  : monomeric form of hCE-1. For RT-PCR analysis, human tissue total RNA was purchased from BD Science Clontech and total RNA of Caco-2 cell was extracted. RT-PCR analysis of hCE1 and hCE2 mRNA was performed with TaKaRa Ex Taq. 
